3

FORM 3 SUBMISSION

Company: Crinetics Pharmaceuticals, Inc.
Filed: July 17, 2018
Period of Report: July 17, 2018
Accession Number: 0000899243-18-019964

View Document ↗ View on SEC.gov ↗